1/16
10:57 am
ebs
?Emergent BioSolutions (EBS) Receives a New Order from US Department of War [Yahoo! Finance]
Low
Report
?Emergent BioSolutions (EBS) Receives a New Order from US Department of War [Yahoo! Finance]
1/15
06:04 pm
ebs
New York Sues Former C.E.O. of Covid Vaccine Maker Over Insider Trading [The New York Times]
Low
Report
New York Sues Former C.E.O. of Covid Vaccine Maker Over Insider Trading [The New York Times]
1/15
05:52 pm
ebs
Former biotech CEO sued over COVID vaccine alleged insider trading [Yahoo! Finance]
Low
Report
Former biotech CEO sued over COVID vaccine alleged insider trading [Yahoo! Finance]
1/14
08:00 am
ebs
Emergent BioSolutions Receives U.S. FDA Approval on Supplemental New Drug Application for NARCAN® Nasal Spray to be Packaged in a New Carrying Case, Making Life-Saving Naloxone More Accessible for Everyday Preparedness
Low
Report
Emergent BioSolutions Receives U.S. FDA Approval on Supplemental New Drug Application for NARCAN® Nasal Spray to be Packaged in a New Carrying Case, Making Life-Saving Naloxone More Accessible for Everyday Preparedness
1/12
07:30 am
ebs
Emergent BioSolutions Announces $100 Million Paydown of Term Loan Principal, a Significant Step Achieved Toward its Multi-year Transformation
Medium
Report
Emergent BioSolutions Announces $100 Million Paydown of Term Loan Principal, a Significant Step Achieved Toward its Multi-year Transformation
1/8
04:30 pm
ebs
Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026
Low
Report
Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026
1/8
08:00 am
ebs
Emergent BioSolutions and PANTHER Announce Agreement to Support the Continuation of the Africa CDC-led MpOx Study in Africa
Medium
Report
Emergent BioSolutions and PANTHER Announce Agreement to Support the Continuation of the Africa CDC-led MpOx Study in Africa
1/7
07:59 am
ebs
Emergent BioSolutions to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
Medium
Report
Emergent BioSolutions to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
12/16
08:05 am
ebs
Emergent Biosolutions (NYSE:EBS) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Low
Report
Emergent Biosolutions (NYSE:EBS) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
12/12
08:30 am
ebs
Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site
Medium
Report
Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site
12/2
03:41 pm
ebs
Emergent Biosolutions (NYSE:EBS) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Emergent Biosolutions (NYSE:EBS) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
11/30
03:33 am
ebs
Emergent Biosolutions (NYSE:EBS) was upgraded by analysts at
Wall Street
Medium
Report
Emergent Biosolutions (NYSE:EBS) was upgraded by analysts at
Wall Street
11/26
02:06 pm
ebs
Emergent Biosolutions (NYSE:EBS) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Emergent Biosolutions (NYSE:EBS) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
11/18
08:00 am
ebs
Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access
Low
Report
Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access
11/12
04:27 pm
ebs
Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors [Yahoo! Finance]
Low
Report
Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors [Yahoo! Finance]
11/12
04:01 pm
ebs
Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors
Medium
Report
Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors
11/11
02:00 pm
ebs
PDA Releases Three New Foundational Documents to Advance Aseptic Processing and Sterilizing Filtration Practices
Low
Report
PDA Releases Three New Foundational Documents to Advance Aseptic Processing and Sterilizing Filtration Practices
11/9
01:13 am
ebs
Emergent Biosolutions (NYSE:EBS) was upgraded by analysts at
Wall Street
Medium
Report
Emergent Biosolutions (NYSE:EBS) was upgraded by analysts at
Wall Street
11/1
01:04 am
ebs
Emergent Biosolutions (NYSE:EBS) was upgraded by analysts at
Wall Street
High
Report
Emergent Biosolutions (NYSE:EBS) was upgraded by analysts at
Wall Street
10/29
04:15 pm
ebs
Emergent BioSolutions Reports Third Quarter 2025 Financial Results
High
Report
Emergent BioSolutions Reports Third Quarter 2025 Financial Results
10/28
08:00 am
ebs
Emergent BioSolutions Releases New Survey Findings Revealing Heightened Concerns About Biological Threats and U.S. Preparedness
Medium
Report
Emergent BioSolutions Releases New Survey Findings Revealing Heightened Concerns About Biological Threats and U.S. Preparedness
10/28
06:18 am
ebs
Emergent Biosolutions (NYSE:EBS) was upgraded by analysts at Zacks Research to a "hold" rating.
Low
Report
Emergent Biosolutions (NYSE:EBS) was upgraded by analysts at Zacks Research to a "hold" rating.
10/24
12:21 pm
ebs
Emergent Biosolutions (NYSE:EBS) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Emergent Biosolutions (NYSE:EBS) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.